RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Age-Related Morbidity and Mortality among Patients with COVID-19

      한글로보기

      https://www.riss.kr/link?id=A106931654

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      On March 11, 2020, the World Health Organization declared coronavirus disease (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. During the COVID-19 pandemic, an age-associated vulnerability in the burden of disease has been uncovered. Understanding the spectrum of illness and the pathogenic mechanism of the disease in a vulnerable population is critical, especially during the pandemic. Herein, we reviewed published COVID-19 epidemiology data from several countries to identify any consistent trends in the relationship between age and COVID-19-associated morbidity or mortality. We also reviewed the literature for studies explaining the difference in the host response to SARS-CoV-2 infection according to age. The insights from these data will be useful in determining the treatment policies and preventive measures of COVID-19.
      번역하기

      On March 11, 2020, the World Health Organization declared coronavirus disease (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. During the COVID-19 pandemic, an age-associated vulnera...

      On March 11, 2020, the World Health Organization declared coronavirus disease (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a pandemic. During the COVID-19 pandemic, an age-associated vulnerability in the burden of disease has been uncovered. Understanding the spectrum of illness and the pathogenic mechanism of the disease in a vulnerable population is critical, especially during the pandemic. Herein, we reviewed published COVID-19 epidemiology data from several countries to identify any consistent trends in the relationship between age and COVID-19-associated morbidity or mortality. We also reviewed the literature for studies explaining the difference in the host response to SARS-CoV-2 infection according to age. The insights from these data will be useful in determining the treatment policies and preventive measures of COVID-19.

      더보기

      참고문헌 (Reference)

      1 Cristiani L, "Will children reveal their secret? The coronavirus dilemma" 55 : 2000749-, 2020

      2 Kim DH, "Understanding and interpretation of case fatality rate of coronavirus disease 2019" 35 : e137-, 2020

      3 Fu Y, "Understanding SARS-CoV-2-mediated inflammatory responses : from mechanisms to potential therapeutic tools" 1-6, 2020

      4 Tay MZ, "The trinity of COVID-19 : immunity, inflammation and intervention" 20 : 363-374, 2020

      5 Bouvier NM, "The future of influenza vaccines: a historical and clinical perspective" 6 : 58-, 2018

      6 The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, "The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020" 2 : 113-122, 2020

      7 Korea Centers for Disease Control and Prevention (KCDC), "Status of COVID-19 in Korea"

      8 Stockman LJ, "Severe acute respiratory syndrome in children" 26 : 68-74, 2007

      9 Leung CW, "Severe acute respiratory syndrome among children" 113 : e535-e543, 2004

      10 DeBiasi RL, "Severe COVID-19 in children and young adults in the Washington, DC metropolitan region" 2020

      1 Cristiani L, "Will children reveal their secret? The coronavirus dilemma" 55 : 2000749-, 2020

      2 Kim DH, "Understanding and interpretation of case fatality rate of coronavirus disease 2019" 35 : e137-, 2020

      3 Fu Y, "Understanding SARS-CoV-2-mediated inflammatory responses : from mechanisms to potential therapeutic tools" 1-6, 2020

      4 Tay MZ, "The trinity of COVID-19 : immunity, inflammation and intervention" 20 : 363-374, 2020

      5 Bouvier NM, "The future of influenza vaccines: a historical and clinical perspective" 6 : 58-, 2018

      6 The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, "The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020" 2 : 113-122, 2020

      7 Korea Centers for Disease Control and Prevention (KCDC), "Status of COVID-19 in Korea"

      8 Stockman LJ, "Severe acute respiratory syndrome in children" 26 : 68-74, 2007

      9 Leung CW, "Severe acute respiratory syndrome among children" 113 : e535-e543, 2004

      10 DeBiasi RL, "Severe COVID-19 in children and young adults in the Washington, DC metropolitan region" 2020

      11 Cao Q, "SARS-CoV-2 infection in children : transmission dynamics and clinical characteristics" 119 : 670-673, 2020

      12 Nikolich-Zugich J, "SARS-CoV-2 and COVID-19 in older adults : what we may expect regarding pathogenesis, immune responses, and outcomes" 42 : 505-514, 2020

      13 de Wit E, "SARS and MERS : recent insights into emerging coronaviruses" 14 : 523-534, 2016

      14 Leung C, "Risk factors for predicting mortality in elderly patients with COVID-19 : a review of clinical data in China" 188 : 111255-, 2020

      15 World Health Organization (WHO), "Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)"

      16 Vaduganathan M, "Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19" 382 : 1653-1659, 2020

      17 Gorse GJ, "Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum" 17 : 1875-1880, 2010

      18 Zhang ZJ, "Novel coronavirus infection in newborn babies zzzzzz28 days in China" 55 : 2000697-, 2020

      19 Wei M, "Novel coronavirus infection in hospitalized infants under 1 year of age in China" 323 : 1313-1314, 2020

      20 World Health Organization (WHO), "Multisystem inflammatory syndrome in children and adolescents with COVID-19"

      21 Tilocca B, "Molecular basis of COVID-19 relationships in different species : a one health perspective" 22 : 218-220, 2020

      22 Mitroulis I, "Modulation of myelopoiesis progenitors is an integral component of trained immunity" 172 : 147-161.e12, 2018

      23 Thabet F, "Middle East respiratory syndrome coronavirus in children" 36 : 484-486, 2015

      24 Memish ZA, "Middle East respiratory syndrome coronavirus disease in children" 33 : 904-906, 2014

      25 Bartenfeld M, "Middle East respiratory syndrome coronavirus and children" 56 : 187-189, 2017

      26 Tosato F, "Lymphocytes subsets reference values in childhood" 87 : 81-85, 2015

      27 Negro F, "Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?" 150 : w20249-, 2020

      28 Bonafè M, "Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes" 2020

      29 김탁, "Improving Preparedness for and Response to Coronavirus Disease 19 (COVID-19) in Long-Term Care Hospitals in Korea" 대한감염학회 52 (52): 133-141, 2020

      30 Riphagen S, "Hyperinflammatory shock in children during COVID-19 pandemic" 395 : 1607-1608, 2020

      31 Prill MM, "Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls" 31 : 235-240, 2012

      32 Koo Bo Kyung, "Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening" 대한감염학회 52 (52): 219-221, 2020

      33 The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare (CEBM), "Global covid-19 case fatality rates"

      34 Hu X, "Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19" 728 : 138812-, 2020

      35 Oliva J, "Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016" 12 : 161-170, 2018

      36 Dong Y, "Epidemiology of COVID-19 among children in China" 145 : e20200702-, 2020

      37 Bi Q, "Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study" 2020

      38 Istituto Superiore di Sanità, "Epidemia COVID-19"

      39 Glowacka I, "Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63" 84 : 1198-1205, 2010

      40 Kim YJ, "Defining association between COVID-19 and the multisystem inflammatory syndrome in children through the pandemic" 35 : e204-, 2020

      41 Office for National Statics, "Deaths registered weekly in England and Wales, provisional: week ending 8 May 2020"

      42 Ferrario CM, "Counterregulatory actions of angiotensin-(1-7)" 30 : 535-541, 1997

      43 NYC Department of Health and Mental Hygiene, "Coronavirus-data"

      44 Zimmermann P, "Coronavirus infections in children including COVID-19 : an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children" 39 : 355-368, 2020

      45 World Health Organization (WHO), "Coronavirus disease (COVID-2019) situation report -110"

      46 Castle SC, "Clinical relevance of age-related immune dysfunction" 31 : 578-585, 2000

      47 Leung C, "Clinical features of deaths in the novel coronavirus epidemic in China" 30 : e2103-, 2020

      48 Liu K, "Clinical features of COVID-19 in elderly patients : a comparison with young and middle-aged patients" 80 : e14-e18, 2020

      49 Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study" 395 : 1054-1062, 2020

      50 von der Beck D, "Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data" 12 : e0180920-, 2017

      51 Statistics Korea, "Cause-of-death statistics in 2018"

      52 COVID-19 National Incident Room Surveillance Team, "COVID-19, Australia: epidemiology report 6 (Reporting week ending 19:00 AEDT 7 March 2020)" 44-, 2020

      53 Cesari M, "COVID-19 in Italy : ageism and decision making in a pandemic" 21 : 576-577, 2020

      54 Natale A, "COVID-19 cases and case fatality rate by age. Knowledge for policy"

      55 Jones VG, "COVID-19 and Kawasaki disease : novel virus and novel case" 10 : 537-540, 2020

      56 Kadkhoda K, "COVID-19 : an immunopathological view" 5 : e00344-20, 2020

      57 Sodhi CP, "Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/ BKB1R axis and facilitates LPS-induced neutrophil infiltration" 314 : L17-L31, 2018

      58 Lee PI, "Are children less susceptible to COVID-19?" 53 : 371-372, 2020

      59 Takada A, "Antibody-dependent enhancement of viral infection : molecular mechanisms and in vivo implications" 13 : 387-398, 2003

      60 Tikellis C, "Angiotensin-converting enzyme 2(ACE2)Is a key modulator of the renin angiotensin system in health and disease" 2012 : 256294-, 2012

      61 Imai Y, "Angiotensin-converting enzyme 2 protects from severe acute lung failure" 436 : 112-116, 2005

      62 Yu P, "Age-related rhesus macaque models of COVID-19" 3 : 93-97, 2020

      63 Xie X, "Age-and gender-related difference of ACE2 expression in rat lung" 78 : 2166-2171, 2006

      64 Greer AL, "Age, influenza pandemics and disease dynamics" 138 : 1542-1549, 2010

      65 Monto AS, "Acute respiratory illness in an American community. The Tecumseh study" 227 : 164-169, 1974

      66 Kam KQ, "A well infant with coronavirus disease 2019 (COVID-19) with high viral load" 2020

      67 Promislow DEL, "A geroscience perspective on COVID-19 mortality" 2020

      68 Taubenberger JK, "1918 Influenza : the mother of all pandemics" 12 : 15-22, 2006

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-02-25 학술지명변경 한글명 : 감염과화학요법 -> Infection and Chemotherapy
      외국어명 : Infection and Chemotherapy -> 미등록
      KCI등재후보
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2009-08-25 학술지명변경 외국어명 : 미등록 -> Infection and Chemotherapy KCI등재후보
      2008-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2008-01-01 평가 등재후보 탈락 (등재후보1차)
      2006-01-01 평가 등재후보 1차 FAIL (등재후보2차) KCI등재후보
      2005-05-27 학술지등록 한글명 : 감염과화학요법
      외국어명 : 미등록
      KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.24 0.24 0.24
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.2 0.2 0.46 0.29
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼